AstraZeneca’s vaccine has reached phase three clinical trials

79
3352
Spread the love

AstraZeneca’s vaccine has reached phase three clinical trials
AstraZeneca’s vaccine has reached phase three clinical trials.Report says it shows potential immune response in the trials.
Astrazeneca or also called AZD1222 or ChAdOx1 nCoV-19.Developed by Oxford University.
India’s Serum Institute partnered with oxford university said it will price the shot at $3 per dose in india.


Spread the love

WordPress database error: [Table './riditmed_wp933/wpk5_comments' is marked as crashed and last (automatic?) repair failed]
SELECT SQL_CALC_FOUND_ROWS wpk5_comments.comment_ID FROM wpk5_comments WHERE ( comment_approved = '1' ) AND comment_post_ID = 1479 ORDER BY wpk5_comments.comment_date_gmt ASC, wpk5_comments.comment_ID ASC

LEAVE A REPLY

Please enter your comment!
Please enter your name here